Home LiteratureArticle Details
PMID: 15557619 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Relative contributions of Pseudomonas aeruginosa ExoU, ExoS, and ExoT to virulence in the lung.

Infection and immunity ·Vol. 72 ·No. 12 ·2004-12-00 ·Pages 6969-77

Shaver CM, Hauser AR

Abstract

Pseudomonas aeruginosa uses a type III secretion system to promote development of severe disease, particularly in patients with impaired immune defenses. While the biochemical and enzymatic functions of ExoU, ExoS, and ExoT, three effector proteins secreted by this system, are well defined, the relative roles of each protein in the pathogenesis of acute infections is not clearly understood. Since ExoU and ExoS are usually not secreted by the same strain, it has been difficult to directly compare the effects of these proteins during infection. In the work described here, several isogenic mutants of a bacterial strain that naturally secretes ExoU, ExoS, and ExoT were generated to carefully evaluate the relative contribution of each effector protein to pathogenesis in a mouse model of acute pneumonia. Measurements of mortality, bacterial persistence in the lung, and dissemination indicated that secretion of ExoU had the greatest impact on virulence while secretion of ExoS had an intermediate effect and ExoT had a minor effect. It is of note that these results conclusively show for the first time that ExoS is a virulence factor. Infection with isogenic mutants secreting wild-type ExoS, ExoS defective in GTPase-activating protein (GAP) activity, or ExoS defective in ADP-ribosyltransferase activity demonstrated that the virulence of ExoS was largely dependent on its ADP-ribosyltransferase activity. The GAP activity of this protein had only a minor effect in vivo. The relative virulence associated with each of these type III effector proteins may have important prognostic implications for patients infected with P. aeruginosa.

MeSH Terms
ADP Ribose Transferases/toxicity Acute Disease Animals Bacterial Proteins/toxicity Bacterial Toxins/toxicity Female GTPase-Activating Proteins Lung/microbiology Mice Mice, Inbred BALB C Pneumonia, Bacterial/etiology Pseudomonas aeruginosa/pathogenicity Virulence
Chemicals
Bacterial Proteins Bacterial Toxins ExoT protein, Pseudomonas aeruginosa GTPase-Activating Proteins pseudomonas exoprotein A protein, Pseudomonas aeruginosa ADP Ribose Transferases exoenzyme S
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Shaver Ciara M
Department of Microbiology, Northwestern University Feinberg School of Medicine, 303 East Chicago Ave., Searle 6-495, Chicago, IL 60611, USA.
Hauser Alan R
References (58)
58 references, click to expand
  1. Exoproduct secretions of Pseudomonas aeruginosa strains influence severity of alveolar epithelial injury.
    Am J Physiol. 1994 Nov;267(5 Pt 1):L551-6 PMID: 7977765
  2. Type III protein secretion is associated with poor clinical outcomes in patients with ventilator-associated pneumonia caused by Pseudomonas aeruginosa.
    Crit Care Med. 2002 Mar;30(3):521-8 PMID: 11990909
  3. An improved system for gene replacement and xylE fusion analysis in Pseudomonas aeruginosa.
    Gene. 1995 May 26;158(1):15-22 PMID: 7789804
  4. Functional domains of Pseudomonas aeruginosa exoenzyme S.
    Infect Immun. 1995 Aug;63(8):3182-6 PMID: 7622246
  5. Identification of glutamic acid 381 as a candidate active site residue of Pseudomonas aeruginosa exoenzyme S.
    Biochemistry. 1996 Feb 27;35(8):2754-8 PMID: 8611582
  6. Genetic relationship between the 53- and 49-kilodalton forms of exoenzyme S from Pseudomonas aeruginosa.
    J Bacteriol. 1996 Mar;178(5):1412-9 PMID: 8631719
  7. Relationship between cytotoxicity and corneal epithelial cell invasion by clinical isolates of Pseudomonas aeruginosa.
    Infect Immun. 1996 Jun;64(6):2288-94 PMID: 8675339
  8. Exoenzyme S of Pseudomonas aeruginosa is secreted by a type III pathway.
    Mol Microbiol. 1996 Dec;22(5):991-1003 PMID: 8971719
  9. Biochemical relationships between the 53-kilodalton (Exo53) and 49-kilodalton (ExoS) forms of exoenzyme S of Pseudomonas aeruginosa.
    J Bacteriol. 1997 Mar;179(5):1609-13 PMID: 9045820
  10. Identification of Pseudomonas aeruginosa genes required for epithelial cell injury.
    Mol Microbiol. 1997 Jun;24(6):1249-62 PMID: 9218773
  11. ExoU expression by Pseudomonas aeruginosa correlates with acute cytotoxicity and epithelial injury.
    Mol Microbiol. 1997 Aug;25(3):547-57 PMID: 9302017
  12. Intracellular targeting of exoenzyme S of Pseudomonas aeruginosa via type III-dependent translocation induces phagocytosis resistance, cytotoxicity and disruption of actin microfilaments.
    Mol Microbiol. 1997 Sep;25(6):1125-39 PMID: 9350868
  13. Identification of type III secreted products of the Pseudomonas aeruginosa exoenzyme S regulon.
    J Bacteriol. 1997 Nov;179(22):7165-8 PMID: 9371466
  14. PepA, a secreted protein of Pseudomonas aeruginosa, is necessary for cytotoxicity and virulence.
    Mol Microbiol. 1998 Feb;27(4):807-18 PMID: 9515706
  15. Defects in type III secretion correlate with internalization of Pseudomonas aeruginosa by epithelial cells.
    Infect Immun. 1998 Apr;66(4):1413-20 PMID: 9529061
  16. ExoY, an adenylate cyclase secreted by the Pseudomonas aeruginosa type III system.
    Proc Natl Acad Sci U S A. 1998 Nov 10;95(23):13899-904 PMID: 9811898
  17. Interruption of multiple cellular processes in HT-29 epithelial cells by Pseudomonas aeruginosa exoenzyme S.
    Infect Immun. 1999 Jun;67(6):2847-54 PMID: 10338490
  18. The N-terminal domain of Pseudomonas aeruginosa exoenzyme S is a GTPase-activating protein for Rho GTPases.
    J Biol Chem. 1999 Dec 17;274(51):36369-72 PMID: 10593930
  19. ExoT of cytotoxic Pseudomonas aeruginosa prevents uptake by corneal epithelial cells.
    Infect Immun. 2000 Jan;68(1):403-6 PMID: 10603417
  20. Mutation of csk, encoding the C-terminal Src kinase, reduces Pseudomonas aeruginosa internalization by mammalian cells and enhances bacterial cytotoxicity.
    Microb Pathog. 2002 Sep;33(3):135-43 PMID: 12220990
  21. Exoenzyme S shows selective ADP-ribosylation and GTPase-activating protein (GAP) activities towards small GTPases in vivo.
    Biochem J. 2002 Nov 1;367(Pt 3):617-28 PMID: 12132999
  22. Intracellular localization modulates targeting of ExoS, a type III cytotoxin, to eukaryotic signalling proteins.
    Mol Microbiol. 2002 Dec;46(5):1381-90 PMID: 12453223
  23. Defective CD8 T cell memory following acute infection without CD4 T cell help.
    Science. 2003 Apr 11;300(5617):339-42 PMID: 12690202
  24. The mechanism of action of the Pseudomonas aeruginosa-encoded type III cytotoxin, ExoU.
    EMBO J. 2003 Jun 16;22(12):2959-69 PMID: 12805211
  25. Characterization of Pseudomonas aeruginosa exoenzyme S as a bifunctional enzyme in J774A.1 macrophages.
    Infect Immun. 2003 Sep;71(9):5296-305 PMID: 12933877
  26. In vivo phospholipase activity of the Pseudomonas aeruginosa cytotoxin ExoU and protection of mammalian cells with phospholipase A2 inhibitors.
    J Biol Chem. 2003 Oct 17;278(42):41326-32 PMID: 12915403
  27. Secretion of the toxin ExoU is a marker for highly virulent Pseudomonas aeruginosa isolates obtained from patients with hospital-acquired pneumonia.
    J Infect Dis. 2003 Dec 1;188(11):1695-706 PMID: 14639541
  28. An adenylate cyclase-controlled signaling network regulates Pseudomonas aeruginosa virulence in a mouse model of acute pneumonia.
    Infect Immun. 2004 Mar;72(3):1677-84 PMID: 14977975
  29. The roles of various fractions of Pseudomonas aeruginosa in its pathogenesis. II. Effects of lecithinase and protease.
    J Infect Dis. 1966 Feb;116(1):112-6 PMID: 4956054
  30. Cleavage of structural proteins during the assembly of the head of bacteriophage T4.
    Nature. 1970 Aug 15;227(5259):680-5 PMID: 5432063
  31. Production of exoenzyme S during Pseudomonas aeruginosa infections of burned mice.
    Infect Immun. 1979 Jun;24(3):837-42 PMID: 112058
  32. Isolation and characterization of transposon-induced mutants of Pseudomonas aeruginosa deficient in production of exoenzyme S.
    Infect Immun. 1984 Aug;45(2):470-4 PMID: 6086529
  33. Contribution of exoenzyme S to the virulence of Pseudomonas aeruginosa.
    Antibiot Chemother (1971). 1985;36:40-8 PMID: 2988426
  34. The contribution of exoproducts to virulence of Pseudomonas aeruginosa.
    Can J Microbiol. 1985 Apr;31(4):387-92 PMID: 2988728
  35. Role of exoenzyme S in chronic Pseudomonas aeruginosa lung infections.
    Eur J Clin Microbiol. 1985 Apr;4(2):175-9 PMID: 2988945
  36. Cloning and sequence analysis of a trans-regulatory locus required for exoenzyme S synthesis in Pseudomonas aeruginosa.
    J Bacteriol. 1991 Oct;173(20):6460-8 PMID: 1655713
  37. Alveolar epithelial injury and pleural empyema in acute P. aeruginosa pneumonia in anesthetized rabbits.
    J Appl Physiol (1985). 1993 Oct;75(4):1661-9 PMID: 8282618
  38. ADP-ribosylation of oncogenic Ras proteins by pseudomonas aeruginosa exoenzyme S in vivo.
    Mol Microbiol. 1999 Jun;32(5):1054-64 PMID: 10361307
  39. Differential sensitivity of human epithelial cells to Pseudomonas aeruginosa exoenzyme S.
    Infect Immun. 1999 Jul;67(7):3494-503 PMID: 10377131
  40. Pseudomonas aeruginosa gene products PilT and PilU are required for cytotoxicity in vitro and virulence in a mouse model of acute pneumonia.
    Infect Immun. 1999 Jul;67(7):3625-30 PMID: 10377148
  41. Pathogenesis of septic shock in Pseudomonas aeruginosa pneumonia.
    J Clin Invest. 1999 Sep;104(6):743-50 PMID: 10491409
  42. Pseudomonas aeruginosa induces type-III-secretion-mediated apoptosis of macrophages and epithelial cells.
    Infect Immun. 1999 Oct;67(10):5530-7 PMID: 10496945
  43. Acetylornithinase of Escherichia coli: partial purification and some properties.
    J Biol Chem. 1956 Jan;218(1):97-106 PMID: 13278318
  44. Intracellular expression of the ADP-ribosyltransferase domain of Pseudomonas exoenzyme S is cytotoxic to eukaryotic cells.
    Mol Microbiol. 1998 Nov;30(4):751-9 PMID: 10094623
  45. Pseudomonas aeruginosa exoenzyme S is a biglutamic acid ADP-ribosyltransferase.
    Infect Immun. 1999 Mar;67(3):1508-10 PMID: 10024602
  46. Active and passive immunization with the Pseudomonas V antigen protects against type III intoxication and lung injury.
    Nat Med. 1999 Apr;5(4):392-8 PMID: 10202927
  47. Integration-proficient plasmids for Pseudomonas aeruginosa: site-specific integration and use for engineering of reporter and expression strains.
    Plasmid. 2000 Jan;43(1):59-72 PMID: 10610820
  48. Pseudomonas aeruginosa cystic fibrosis isolates induce rapid, type III secretion-dependent, but ExoU-independent, oncosis of macrophages and polymorphonuclear neutrophils.
    Infect Immun. 2000 May;68(5):2916-24 PMID: 10768989
  49. Acquisition of expression of the Pseudomonas aeruginosa ExoU cytotoxin leads to increased bacterial virulence in a murine model of acute pneumonia and systemic spread.
    Infect Immun. 2000 Jul;68(7):3998-4004 PMID: 10858214
  50. Pseudomonas aeruginosa ExoT is a Rho GTPase-activating protein.
    Infect Immun. 2000 Oct;68(10):6066-8 PMID: 10992524
  51. The arginine finger domain of ExoT contributes to actin cytoskeleton disruption and inhibition of internalization of Pseudomonas aeruginosa by epithelial cells and macrophages.
    Infect Immun. 2000 Dec;68(12):7100-13 PMID: 11083836
  52. Type III secretion/intoxication system important in virulence of Pseudomonas aeruginosa infections in burns.
    Burns. 2001 Mar;27(2):129-30 PMID: 11226648
  53. Type III protein secretion is associated with death in lower respiratory and systemic Pseudomonas aeruginosa infections.
    J Infect Dis. 2001 Jun 15;183(12):1767-74 PMID: 11372029
  54. Independent and coordinate effects of ADP-ribosyltransferase and GTPase-activating activities of exoenzyme S on HT-29 epithelial cell function.
    Infect Immun. 2001 Sep;69(9):5318-28 PMID: 11500401
  55. Prevalence of type III secretion genes in clinical and environmental isolates of Pseudomonas aeruginosa.
    Microbiology. 2001 Oct;147(Pt 10):2659-69 PMID: 11577145
  56. In vivo rho GTPase-activating protein activity of Pseudomonas aeruginosa cytotoxin ExoS.
    Infect Immun. 2002 Jan;70(1):360-7 PMID: 11748202
  57. Pseudomonas aeruginosa ExoT acts in vivo as a GTPase-activating protein for RhoA, Rac1, and Cdc42.
    Infect Immun. 2002 Apr;70(4):2198-205 PMID: 11895987
  58. Characterization of Pseudomonas aeruginosa-induced MDCK cell injury: glycosylation-defective host cells are resistant to bacterial killing.
    Infect Immun. 1995 Apr;63(4):1541-51 PMID: 7890421
Article Info
Journal
Infection and immunity
Abbr.
Infect Immun
ISSN
0019-9567
Published
2004-12-00
Pages
6969-77
Language
English
Region
United States
NLM ID
0246127
PMCID
PMC529154
Subset
IM
Grants
NIAID NIH HHS · AI 07476-07 · United States
NIAID NIH HHS · T32 AI007476 · United States
NIAID NIH HHS · R01 AI053674 · United States
NIEHS NIH HHS · F30 ES013082 · United States
NIAID NIH HHS · AI 053674 · United States
NIEHS NIH HHS · ES 013082 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]